utrophil Engraftment: ANC > 0.5 x 10^9/L for three consecutive days. Platelet Engraftment: Platelet count > 20 x 10^9/L without transfusions for three days. Management of Complications Infections: Bacterial, viral, fungal; prophylactic and preemptive therapies. Graft-versus-host Disea
phoblastic Leukemia (ALL): Particularly in relapsed or refractory cases. Chronic Myeloid Leukemia (CML): Historically, less common now due to targeted therapies, but still relevant for advanced or resistant cases. Multiple Myeloma: Autologous BMT is standard for eligible patients. Lymp
ts and Innovations in Bone Marrow Transplantation The field of hematology continually advances to improve outcomes and reduce complications associated with BMT. Reduced-Intensity Conditioning (RIC) Traditional conditioning regimens are intensive, but RIC uses lower doses of chemotherapy and r
